Fierce Pharma
JULY 3, 2024
After more than a decade with no treatment advances for chronic obstructive pulmonary disease (COPD), two have been approved by regulators on either side of the Atlantic within a week. | After more than a decade with no treatment advances for chronic obstructive pulmonary disease (COPD), two have been approved by regulators on either side of the Atlantic within a week.
pharmaphorum
JULY 3, 2024
Beacon Therapeutics raises $170m for a pivotal trial of its gene therapy for X-linked retinitis pigmentosa, an inherited cause of blindness
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JULY 3, 2024
Abbott recently launched the FreeStyle Libre 3 Plus sensor, which it says is the smallest and most discreet sensor on the market. It will soon be available in U.S. retail pharmacies and medical equipment suppliers. The post Abbott Says Its Latest CGM Sensor Is Its Most Discreet Yet appeared first on MedCity News.
pharmaphorum
JULY 3, 2024
Eli Lilly finally has FDA approval for its amyloid-busting Alzheimer’s disease therapy donanemab and will launch it at a cost it claims could deliver savings compared to a rival therapy from Eisai/Biogen.
MedCity News
JULY 3, 2024
The Rise Fund will lead a $200 million investment in Foodsmart. The funding will help the telenutrition company scale its business. The post Foodsmart Snags $200M Investment Led By TPG’s Rise Fund appeared first on MedCity News.
pharmaphorum
JULY 3, 2024
EU is first to approve Sanofi and Regeneron's Dupixent for COPD, ending a 10-year hiatus in new therapies
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
JULY 3, 2024
GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID-19 jabs.
MedCity News
JULY 3, 2024
Finding a payment technology solution that is specifically designed for alternative payment models like capitation helps payers and providers achieve financial sustainability in a value-based system. The post Capitation Technology Drives Financial Viability in Value-Based Care Models appeared first on MedCity News.
Pharmaceutical Technology
JULY 3, 2024
Academic institutions and nonprofit organisations are jumping in to save access to complex gene therapies.
MedCity News
JULY 3, 2024
Data exchange lies at the heart of innovation. With the right data available, BioPharma companies can best implement advanced analytics tools for timely interventions in manufacturing deficiencies and optimize processes. The post Ensuring Data Integrity in BioPharmaceutical Manufacturing: The Need for Contextualization and Cloud-based Integration appeared first on MedCity News.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PharmaTimes
JULY 3, 2024
Dementias, including Alzheimer’s disease, are estimated to affect 944,000 people in the UK
pharmaphorum
JULY 3, 2024
J&J’s multiple myeloma CAR-T Carvykti improves survival when used as a second-line or later therapy, raising the pressure on BMS’ rival Abecma
PharmaTimes
JULY 3, 2024
Chronic migraine is a neurological condition estimated to affect up to 2.
Clarivate
JULY 3, 2024
The medical technology industry is emerging from a turbulent pandemic era strong, with some really exciting innovations making their way to patients, several of which we showcased in our recent Medical Technologies to Watch report. However, to realize the promise of these and other innovations, MedTech companies must navigate a fast-changing clinical, competitive and regulatory environment that presents a complex web of challenges.
Pharmaceutical Commerce
JULY 3, 2024
The Stelara biosimilar will be commercialized by Sandoz, and is expected to launch by February 2025 for multiple indications, including for the treatment of adult patients with active psoriatic arthritis.
PharmExec
JULY 3, 2024
Funding from the Biomedical Advanced Research and Development Authority (BARDA) is expected to support the late-stage development and licensure of a pre-pandemic vaccine targeting the H5 influenza virus.
PM360
JULY 3, 2024
Former Publicis Chief Digital Officer joins Klick to take its growing Media team into the future Klick Health today announced that healthcare media veteran Ray Rosti has been named President, Klick Media. The agency’s Chief Operating Officer Greg Rice said that Rosti’s proven innovative approach and deep understanding of digital strategies made him the perfect candidate for the new role as Klick continues to expand and enhance its media capabilities. “We are thrilled to welcome Ray as Pres
Pharmaceutical Commerce
JULY 3, 2024
The deal provides the CDMO with ownership of the Lexington facility, allowing for late-phase and commercial gene therapy development and manufacturing of a branded severe Hemophilia B product.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Evolve Your Success
JULY 3, 2024
Join us for an insightful conversation with Vendela Martin, a trailblazing medical sales rep and LinkedIn content creator who transitioned from B2B sales at ADP to an impactful role in medical device sales, specializing in minimally invasive surgery for GYN surgeons. Vendela shares her journey and the pivotal moments that validated her career change, offering a glimpse into the importance of her product and the collaborative dynamics of her team.
Pharmaceutical Technology
JULY 3, 2024
Johnson & Johnson (J&J) has received the US FDA and EC approvals for SIRTURO (bedaquiline) to treat pulmonary tuberculosis (TB).
PharmaVoice
JULY 3, 2024
GeoVax is developing a next-gen COVID vaccine targeting a population that’s so far been elusive: immunocompromised patients.
PharmExec
JULY 3, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
JULY 3, 2024
GSK and CureVac have announced the restructuring of their existing partnership into a new licensing agreement for mRNA vaccine candidates.
PharmExec
JULY 3, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
JULY 3, 2024
Beacon’s lead candidate AGTC-501 is currently in a Phase II/III clinical trial for the treatment of X-linked retinitis pigmentosa (XLRP).
PharmExec
JULY 3, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Pharmaceutical Technology
JULY 3, 2024
Metal contamination in pharmaceutical products is a huge problem. Detection and removal of these contaminants is critical during milling.
PharmaTech
JULY 3, 2024
A greater number of patients with Duchenne muscular dystrophy will be able to be treated after FDA's approval of a gene therapy.
Pharmaceutical Technology
JULY 3, 2024
Moderna has received a grant of $176m through the RRPV Consortium to expedite the development of mRNA-based pandemic influenza vaccines.
Pharmaceutical Commerce
JULY 3, 2024
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Expert insights. Personalized for you.
220 
Let's personalize your content